Evidence map›Paper›PMID 19963266›Full record

ArticleBiomaterials2010

The utilization of pathogen-like cellular trafficking by single chain block copolymer.

Gaurav Sahay, Vivek Gautam, Robert Luxenhofer, Alexander V Kabanov

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  4. Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity.Journal of controlled release : official journal of the Controlled Release Society · 2014
    Article
  5. Agile delivery of protein therapeutics to CNS.Journal of controlled release : official journal of the Controlled Release Society · 2014
    Review
  6. Pluronics and MDR reversal: an update.Molecular pharmaceutics · 2014
    Review
  7. Review
  8. Review
  9. Article
  10. Non-degradative intracellular trafficking of highly compacted polymeric DNA nanoparticles.Journal of controlled release : official journal of the Controlled Release Society · 2012
    Article
  11. Article
  12. Combined pluronic P85- and ultrasound contrast agents-mediated gene transfection to HepG2 cells.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2011
    Article
  13. Review
  14. Article
  15. Endocytosis of nanomedicines.Journal of controlled release : official journal of the Controlled Release Society · 2010
    Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Gaurav SahayDepartment of Pharmaceutical Sciences and Center for Drug Delivery and Nanomedicine, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198-5830, USA.
Vivek Gautam
Robert Luxenhofer
Alexander V Kabanov
University of Nebraska Medical Center · USLomonosov Moscow State University · RU

Funding

Polypeptide Modification for Enhanced Brain DeliveryR01NS051334 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BANKS, WILLIAM A, KABANOV, ALEXANDER V · 2006 to 2014
$2.7M
Pluronic Block Copolymers in Drug Resistant CancerR01CA089225 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI KABANOV, ALEXANDER V · 2001 to 2011
$2.2M
NCI NIH HHS R01 CA089225NCI NIH HHS R01CA089225NINDS NIH HHS R01 NS051334NINDS NIH HHS R01NS051334
6 · The paper itself

Abstract

Amphiphilic triblock copolymer, poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide), Pluronic P85, is unexpectedly shown to utilize sophisticated cellular trafficking mechanisms and enter brain microvessel endothelial cells and primary neurons that are poorly penetrable. Though caveolae serve as a primary entry site for the copolymer single chains, in cells devoid of caveolae, the copolymer can still exploit caveolae- and clathrin-independent routes. This parallels the copolymer's trafficking itinerary with that of biological pathogens. The similarity is reinforced since both bypass early endosomes/lysosomes and transport to the endoplasmic reticulum. The copolymer finally reaches the mitochondrion that serves as its final destination. Notably, it also succeeds to gain entry in brain microvessel endothelial cells through caveolae and in primary neurons through caveolae- and clathrin-independent pathway. In neurons the copolymer accumulates in the cell body followed by anterograde trafficking towards the axons/dendrites. Overall, dissecting the trafficking of a synthetic polymer in multiple cell types triggers development of novel delivery systems that can selectively target intracellular compartments and provide entry in cells currently considered impenetrable.

Indexed as

AnimalsBiological TransportCaveolaeCell LineEndocytosisEndothelial CellsIntracellular SpaceMicroscopy, ConfocalMicrovesselsNeuronsPoloxalenepluronic block copolymer p85Poloxalene

Identifiers

PMID19963266
PMCPMC3070746
OpenAlexW2055571044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.